Organization
Medicine and Frontier Science Center of Disease Molecular Network
17 abstracts
Abstract
Real-world clinical outcomes in Chinese patients with EGFR-mutated NSCLC progressed from first-line EGFR-TKI: A prospective multicenter study.Org: Department of Pulmonary and Critical Care Medicine, Precision Medicine Key Laboratory of Sichuan Province, Suzhou Municipal Hospital, Shenyang Chest Hospital, Medicine and Frontier Science Center of Disease Molecular Network,
Abstract
Hypophosphatemia and thrombocytopenia: A retrospective chart review to identify markers for prediction of CRS and ICANS in CAR T-cell therapy.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, University of Arizona, Tucson, AZ, University of Arizona Cancer Center, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital,
Abstract
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.Org: Cincinnati Children's Hospital Medical Center, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital, Division of Pediatric Hematology-Oncology, Department of Pediatrics, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, QC, Canada, Oncology and Bone Marrow Transplant, School of Medicine & Public Health,
Abstract
“I JUST WANT MY LIFE BACK”: PHYSICAL FUNCTION AND FATIGUE ARE CRITICAL TARGETS FOR IMPROVING PARTICIPATION AND HRQL IN RHEUMATOID ARTHRITIS Org: Medicine and Frontier Science Center of Disease Molecular Network, Mcgill University, Montreal, Canada, Johns Hopkins, Baltimore, United States,
Abstract
"ROUTINE APGAR-LIKE PATIENT INDEX DATASHEET"(RAPID): A CONTINUOUS INDEX OF PATIENT MEASURES DISCRIMINATES EFFECTIVELY BETWEEN ACTIVE AND PLACEBO TREATMENTS IN 4 ADALIMUMAB CLINICAL TRIALSOrg: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, Nashville, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, Quintiles, Inc.,
Abstract
3D CORTICAL BONE MAPPING OF THE PROXIMAL FEMUR IN A LARGE PROSPECTIVE POPULATION-BASED STUDY SUPPORTS THE GANZ HYPOTHESIS OF HIP OSTEOARTHRITIS CAUSATION: THE AGES-REYKJAVIK STUDY Org: Medicine and Frontier Science Center of Disease Molecular Network, Engineering, Cambridge University, Cambridge, United Kingdom, The Icelandic Heart Association, Kopavogur, Medicine, University of Iceland, Reykjavik, Iceland,
Abstract
A COMPARISON OF THE DISCRIMINANT CAPACITY OF THE BASMI (0-10) AND EDASMI MOBILITY INSTRUMENTS IN AS PATIENTS RECEIVING ANTI-TNF TREATMENTOrg: Medicine and Frontier Science Center of Disease Molecular Network, University of Alberta, Edmonton, Canada's Michael Smith Genome Sciences Centre,
Abstract
ACQUIRED HEMOPHILIA: A REPORT OF THREE CASESOrg: Medicine and Frontier Science Center of Disease Molecular Network, Philippine General Hospital, Manila, Manila, Philippines, Manila, Philippines, Philippines,
Abstract
A CROSS-SECTIONAL STUDY OF THE DISEASE ACTIVITY AND DAMAGE INDEX OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN TWO URBAN TERTIARY REFERRAL CENTRES Org: Medicine and Frontier Science Center of Disease Molecular Network, Putrajaya Hospital, Malaysia,
Abstract
A VALIDATION OF CURRENT CLASSIFICATION CRITERIA FOR THE DIAGNOSIS OF PSORIATIC ARTHRITIS – PRELIMINARY RESULTS OF THE CASPAR STUDYOrg: Medicine and Frontier Science Center of Disease Molecular Network, Wellington School of Medicine, Wellington, New Zealand, Academic Unit of Musculoskeletal and Rehabilitation Medicine, University of Leeds,
Abstract
A NEW DISEASE ACTIVITY INDEX BASED ON THE AMERICAN COLLEGE OF RHEUMATOLOGY CORE SET OF DISEASE ACTIVITY MEASURES FOR RHEUMATOID ARTHRITIS: MEAN OUTCOME INDEX FOR RHEUMATOID ARTHRITIS (MOI-RA)Org: Medicine and Frontier Science Center of Disease Molecular Network, Jyväskylä Central Hospital, Rheumatology, Heinola Foundation Hospital, Finland,
Abstract
ACCESS TO TREATMENT FOR RAYNAUD’S PHENOMENON AND DIGITAL ULCERS FOR PATIENTS WITH SYSTEMIC SCLEROSIS DOESN’T FOLLOW EULAR/EUSTAR GUIDELINESOrg: Western University, Medicine and Frontier Science Center of Disease Molecular Network, McGill University Health Center, Rheumatology,
Abstract
ABNORMALITIES OF HIPPOCAMPAL SIGNAL INTENSITY PREDICTS HIPPOCAMPAL ATROPHY IN SYSTEMIC LUPUS ERYTHEMATOSUS Org: Medicine and Frontier Science Center of Disease Molecular Network, Neurology, State University of Campinas, Campinas, Brazil,
Abstract
A COMPOSITE INDEX OF PHYSICAL FUNCTION, PAIN, PATIENT GLOBAL AND JOINT COUNT, RAPID4 (ROUTINE ASSESSMENT OF PATIENT INDEX DATA): VIRTUALLY IDENTICAL RESULTS WITH A PATIENT SELF-REPORT OR PHYSICIAN/ASSESSOR JOINT COUNT OR NO JOINT COUNT IN RAPID3Org: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, Nashville, Arthritis & Rheumatology, Taylor Hospital,
Abstract
A TRANSLATION TEMPLATE FOR PATIENT SELF-REPORT MEDICAL HISTORY AND FUNCTIONAL STATUS QUESTIONNAIRE IN A FIXED, STANDARD 4-PAGE FORMAT TO FACILITATE TRANSLATION WHEN A HEALTH PROFESSIONAL AND PATIENT DO NOT SPEAK THE SAME LANGUAGEOrg: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, NYU Hospital for Joint Diseases, New York,
Abstract
ABCB1AND ABCG2 DRUG-EFFLUX TRANSPORTERS FUNCTION AND ITS ASSOCIATION WITH DISEASE ACTIVITY IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS Org: Medicine and Frontier Science Center of Disease Molecular Network, Rheumatology, Instituto Nacional de Ciencias Médicas y Nutriciόn, Mexico City, Mexico,
Abstract
ABILITY OF MEASURES OF FUNCTION AND INFLAMMATION TO PREDICT LONG-TERM PATIENT-REPORTED DISEASE IMPACT AND DISABILITY IN RAOrg: Medicine and Frontier Science Center of Disease Molecular Network, University of California Irvine, San Francisco Department of Public Health, GHEOR, Amgen,